Equity Research

Analyst Myles Minter Comments on COVID-19 Vax for Children

In this interview with the Boston affiliate of NPRWBUR – research analyst Myles Minter shares his insights on the long-term value, if any, of one COVID-19 vaccine producer, in this case Moderna, being first to market with an approved vaccine for children under the age of five.

Read the full story

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news

Our Latest News

Brightly Software Has Agreed to be Acquired by Siemens

William Blair acted as lead financial advisor to Brightly Software, Inc., a portfolio company of Clearlake Capital Group, L.P., in connection with its pending sale to Siemens AG (FRA:SIE) for $1.575 billion of upfront cash consideration, along with $300 million in cash earn-out payments, for a total of $1.875 billion.

Read more

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures